Biblio Discovery — Demo Discovery Service

6 hasil untuk "David Bauer"

Menampilkan 1–6 · 1,03 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells

    David Bauer; Natalie Redmon; Elizabeth Mazzio dkk.

    PLOS ONE, Vol. 12 No. 4 · 2017 · Inggris · PLOS Scopus

    Mortality associated with breast cancer is attributable to aggressive metastasis, to which TNFα plays a central orchestrating role. TNFα acts on breast tumor TNF receptors evoking the release of chemotactic proteins (e.g. MCP-1/CCL2). These proteins direct inward infiltration/migration of…

  2. Artikel Jurnal Teks lengkap

    The inhibitory effects of butein on cell proliferation and TNF-α-induced CCL2 release in racially different triple negative breast cancer cells

    Patricia Mendonca; Ainsley Horton; David Bauer dkk.

    PLOS ONE, Vol. 14 No. 10 · 2019 · Inggris · PLOS Scopus

    Drug resistance is the leading cause of breast cancer-related mortality in women, and triple negative breast cancer (TNBC) is the most aggressive subtype, affecting African American women more aggressively compared to Caucasians women. Of all cancer-related deaths, 15 to 20% are associated with…

  3. Artikel Jurnal Teks lengkap

    Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients

    Lorenz Balcar; David Bauer; Katharina Pomej dkk.

    PLOS ONE, Vol. 18 No. 4 · 2023 · Inggris · PLOS Scopus

    Background & aims: Immunotherapy represents the new standard of care in systemic first-line treatment of hepatocellular carcinoma (HCC). Biomarkers that predict treatment response and survival remain an unmet clinical need. Methods: Patients with HCC treated with immune-checkpoint inhibitors (ICI)…

  4. Artikel Jurnal Teks lengkap

    Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes

    Michael Schwarz; Caroline Schwarz; Lukas Burghart dkk.

    PLOS ONE, Vol. 18 No. 8 · 2023 · Inggris · PLOS Scopus

    Introduction: Liver cirrhosis accounts for considerable morbidity and mortality worldwide and late presentation limits therapeutic options. We aimed to assess characteristics of patients with liver cirrhosis at the time of first presentation and during their clinical course. Methods: Patients with…

  5. Artikel Jurnal Teks lengkap

    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease

    Michael Eder; Haris Omic; Jana Gorges dkk.

    PLOS ONE, Vol. 16 No. 4 · 2021 · Inggris · PLOS Scopus

    Introduction: Seasonal influenza is a major global health problem causing substantial morbidity and health care costs. Yet, in many countries, the rates of influenza vaccination remain low. Chronic kidney or liver diseases (CKLD) predispose patients to severe influenza infections, but data on…

  6. Artikel Jurnal Teks lengkap

    Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding – A two decades experience

    Theresa Bucsics; Maria Schoder; Magdalena Diermayr dkk.

    PLOS ONE, Vol. 13 No. 1 · 2018 · Inggris · PLOS Scopus

    Background and aims: Transjugular intrahepatic portosystemic shunts (TIPS) are used in patients with cirrhosis for the prevention of variceal rebleeding. Methods: We retrospectively evaluated re-bleeding rate, patency, mortality, and transplant-free survival (TFS) in cirrhotic patients receiving…